|
Market Closed -
NSE India S.E.
07:05:10 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 749.15 INR | +5.92% |
|
+17.21% | +32.60% |
| 07-23 | Solara Active Pharma Sciences Limited, Q1 2027 Earnings Call, Jul 23, 2026 | |
| 07-23 | Solara Active Pharma Sciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 36.15B 378M 326M 309M 280M 525M 528M 3.67B 1.41B 18.39B 1.42B 1.39B 58.11B | P/E 2025 |
3,792x | P/E 2026 | -253x |
|---|---|---|---|---|---|
| Enterprise Value | 42.94B 449M 387M 367M 332M 623M 627M 4.35B 1.67B 21.84B 1.69B 1.65B 69.02B | EV / Sales 2025 |
2.54x | EV / Sales 2026 | 1.99x |
| Free-Float |
47.76% | Yield 2025 * |
-
| Yield 2026 | - |
NSE India S.E.INR
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| SOLARA | Delayed | |
Bombay S.E.
| SOLARA | Delayed |
Last Transcript : Solara Active Pharma Sciences Limited
| 1 day | +5.92% | ||
| 1 week | +17.21% | ||
| Current month | +18.41% | ||
| 1 month | +47.27% | ||
| 3 months | +29.01% | ||
| 6 months | +65.72% | ||
| Current year | +32.60% |
| 1 week | 639.15 |  | 759.55 |
| 1 month | 501.95 | | 759.55 |
| Current year | 422 | | 759.55 |
| 1 year | 422 | | 759.55 |
| 3 years | 286 | | 882.8 |
| 5 years | 286 | | 1,723.4 |
| 10 years | 134.5 | | 1,859.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sandeep Rao
CEO | Chief Executive Officer | - | 2025-02-20 |
Sarat Kumar
DFI | Director of Finance/CFO | - | 2025-02-20 |
Ajit Manocha
CTO | Chief Tech/Sci/R&D Officer | 74 | 2026-08-09 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 2018-04-10 | |
| Director/Board Member | 58 | 2018-04-10 | |
| Director/Board Member | 75 | 2023-11-13 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/14/25 | Buy | Director | 1,000 | 0.0021% | ||
| 3/6/25 | Pronomz Ventures LLP
| Buy | Company | 13,600 | 0.0283% | |
| 3/4/25 | Pronomz Ventures LLP
| Buy | Company | 216,361 | 0.4503% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.92% | +17.21% | +11.13% | +107.15% | 357M | |
| -0.65% | -2.93% | +47.52% | +87.34% | 1,001B | |
| -0.29% | -3.51% | +48.78% | +63.27% | 642B | |
| +0.83% | +0.26% | +16.76% | +72.52% | 451B | |
| -0.38% | -3.59% | +28.24% | +35.57% | 340B | |
| -0.09% | -13.54% | +10.08% | +26.87% | 263B | |
| -0.43% | -2.48% | -2.07% | +11.48% | 247B | |
| -1.34% | -13.70% | +33.47% | +44.18% | 207B | |
| -3.44% | -7.51% | -20.08% | -59.58% | 197B | |
| -0.75% | -4.82% | +21.94% | +86.55% | 180B | |
| Average | -0.06% | -3.76% | +19.58% | +47.54% | 352.67B | |
| Weighted average by Cap. | -0.52% | -4.33% | +29.80% | +55.49% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 12.84B 134M 116M 110M 99.37M 186M 187M 1.3B 501M 6.53B 505M 494M 20.64B | 13.69B 143M 123M 117M 106M 199M 200M 1.39B 534M 6.96B 538M 526M 22.01B |
| Net income | 5.4M 56.52K 48.7K 46.11K 41.8K 78.41K 78.81K 548K 211K 2.75M 212K 208K 8.68M | -74.1M -776K -668K -633K -574K -1.08M -1.08M -7.52M -2.89M -37.7M -2.91M -2.85M -119M |
| Net Debt | 7.92B 82.91M 71.44M 67.64M 61.31M 115M 116M 803M 309M 4.03B 311M 305M 12.73B | 6.79B 71.08M 61.24M 57.99M 52.56M 98.61M 99.11M 689M 265M 3.45B 267M 261M 10.92B |
Employees
1,669
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-11 | ₹749.15 | +5.92% | 1,159,874 |
| 26-09-10 | ₹707.25 | +2.43% | 1,463,549 |
| 26-09-09 | ₹690.50 | -1.61% | 271,068 |
| 26-09-08 | ₹701.80 | +0.68% | 800,696 |
| 26-09-07 | ₹697.05 | +9.06% | 2,187,893 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SOLARA Stock
Select your edition
All financial news and data tailored to specific country editions
